EM Systems CoFRA:EMO 77 ROE % is 0.96% as of Dec. 2025, which is 92% below its 10-year median of 11.89. GuruFocus rates FRA:EMO with a GF Score™ of 77/100 and a GF Value™ of €3.98. The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, EM Systems Co ranks better than 54.46% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. EM Systems Co's annualized net income for the quarter that ended in Dec. 2025 was €1.1 Mil. EM Systems Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €113.9 Mil. Therefore, EM Systems Co's annualized ROE % for the quarter that ended in Dec. 2025 was 0.96%.
The historical rank and industry rank for EM Systems Co's ROE % or its related term are showing as below:
FRA:EMO'
s ROE % Range Over the Past 10 Years
Min: 7.34 Med: 11.89 Max: 16.13
Current: 7.34
During the past 13 years, EM Systems Co's highest ROE % was 16.13%. The lowest was 7.34%. And the median was 11.89%.
FRA:EMO's ROE % is ranked better than 54.46% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs FRA:EMO: 7.34
EM Systems Co (FRA:EMO) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
EM Systems Co ROE % Related Terms
EM Systems Co ROE % Historical Data
* Premium members only.
The historical data trend for EM Systems Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, EM Systems Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EM Systems Co ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EM Systems Co's ROE % distribution charts can be found below:
* The bar in red indicates where EM Systems Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
EM Systems Co (FRA:EMO) has a ROE % of 0.96% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EM Systems Co and its competitors. This is 92% below median its historical median of 11.89. Over the past decade, EM Systems Co's ROE % has ranged from 7.34 to 16.13. According to the industry distribution chart, EM Systems Co ranks #286 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is EM Systems Co's ROE % too high?
EM Systems Co's current ROE % of 0.96% is 92% below median its 10-year median of 11.89. Over the past 10 years, this metric has ranged from a low of 7.34 to a high of 16.13. The Healthcare Providers & Services industry median ROE % is 5.72. EM Systems Co's value of 0.96% is 83.2% below this industry median. Based on the distribution chart, EM Systems Co ranks #286 out of 628 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EM Systems Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does EM Systems Co's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EM Systems Co ranks #286 out of 628 companies for ROE %. This puts EM Systems Co in the upper half of its industry. The industry median ROE % is 5.72. EM Systems Co's value of 0.96% is 83.2% below this benchmark. Historically, EM Systems Co's own ROE % has ranged from 7.34 to 16.13 over the past decade. While the company's 10-year median is 11.89 vs. the industry median of 5.72, EM Systems Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EM Systems Co's current ROE % of 0.96% is 83.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EM Systems Co and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EM Systems Co's current ROE % is 0.96%, which is 92% below median its own 10-year median of 11.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EM Systems Co stock overvalued right now?
EM Systems Co (FRA:EMO) has a current ROE % of 0.96%. The stock's GF Value™ is €3.98, compared to a current price of €2.58 — trading 35.2% below its estimated fair value. The current ROE % is 0.96%, which is 92% below median its 10-year median of 11.89 and 83.2% below the Healthcare Providers & Services industry median of 5.72. EM Systems Co's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For EM Systems Co (FRA:EMO), the current ROE % is 0.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EM Systems Co (FRA:EMO) Overvalued in 2026?
Based on GuruFocus' analysis, EM Systems Co stock appears to be undervalued.
The current stock price of €2.58 is trading 35.2% below its estimated GF Value™ of €3.98.
Key valuation signals for FRA:EMO:
ROE %: 0.96% (92% below median its 10-year median of 11.89)
GF Value™: €3.98 vs. price of €2.58 (35.2% below fair value)
Industry Position: 83.2% below the Healthcare Providers & Services median (#286 of 628)
No single metric tells the full story. See the FRA:EMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EM Systems Co Ltd is a Japan-based company that develops, sells, and maintains systems for the medical (clinics and insurance pharmacies) and nursing/welfare industries. It operates its business in three divisions: Pharmacy System Business develops and sells systems for pharmacies, and provides related supplies and maintenance services; Medical system involved in the development and sales of medical office administration computer systems for medical institutions and clinics; Nursing Care/Welfare Systems Business products are systems for nursing care/welfare service providers and medical and nursing care collaboration solutions; Other businesses operates through its subsidiray that provides promotes cashless payments for clinics and pharmacies and Others services.
77GF Score
Get the complete analysis for FRA:EMO
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EMO has been successfully added to your 
